Skip to content
MedsAcross

Medicine

Alyglo 10000 mg/100 mL injection

Human immunoglobulin g · Intravenous · GC Biopharma
Available on requestPrescription onlyUS FDA Cold chain

Alyglo 10000 mg/100 mL injection is a prescription medicine containing Human immunoglobulin g for intravenous use, marketed by GC Biopharma, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Cold chain

Store ALYGLO in the refrigerator or at room temperature. Refrigeration: 2°C to…

Key facts

Active ingredient (INN)
Human immunoglobulin g
Brand
Alyglo
Strength
10000 mg/100 mL
Dosage form
Injection
Route
Intravenous
Packs
1 vial of 100 mL
Marketing authorisation holder
GC Biopharma
Manufacturer
GC Biopharma
Origin register
US FDA, United States
Storage
Store ALYGLO in the refrigerator or at room temperature. Refrigeration: 2°C to 8°C [36°F to 46°F] for up to 36 months. Do not freeze. Do not return to refrigeration after ALYGLO has been stored at room temperature. Room Temperature: 8°C to 25°C [46°F to 77°F] for up to 24 months.
Cold chain
Yes, shipped temperature controlled
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
J06BA02 Human immunoglobulin g
HS code (indicative)
3002.12Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
15 December 2023
Identifiers
RxCUI 2672098, 2672105, 2672107 +3DailyMed set ID fb97b3ec-29ee-4df1-aa99-c23e57a21228NDC 61476-104Application BLA125743

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
1 vial, glass in 1 carton / 100 mL in 1 vial, glass61476-104-10GC Biopharma15 December 2023

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Human immunoglobulin g 10000 mg/100 mL injection.

Compare all 4

Other strengths and forms of Human immunoglobulin g

Clinical summary

Human immunoglobulin g is a human immunoglobulin G indicated for the treatment of adults and pediatric patients 2 years of age and older with primary humoral immunodeficiency (PI). MedsAcross supplies Human immunoglobulin g for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Human immunoglobulin g

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Alyglo 10000 mg/100 mL injection for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.